The Spinal Cord Meeting ISCORE 2015 Scientific Organizers is formed by experts in neuroscience research. The ISCORE 2015 Scientific Organizers work in leading universities or hospitals in the field of spinal cord injury. They want to promote future collaborations which they expect to be highly fruitful, and to encourage the exchange of information between researchers. Their principal objective: to find a treatment which is so much needed by the patients.
Since 04/2010-Junior Group Leader (Ramon & Cajal Contract): Neuronal Regeneration Lab. Prince Felipe Research Institute (CIPF), Valencia. SPAIN
10/2005-03/2010-Researcher, responsible of the project: Adult Stem Cells in Spinal Cord Regeneration. Prince Felipe Research Institute (CIPF), Valencia. SPAIN
01/2004-09/2005-Researcher of CNIO in collaboration with the Pharmaceutical company Lilly Co. Involved in the study of the complete signalling by using Lilly inhibitors of MAPKs with in vitro and in vivo models (producing genetic modified models: KO and KI conditional mice) National Oncology Research Center. Madrid. SPAIN
02/2003-12/2003-Post-Doctoral Fellow, responsible of the project: Molecular mechanism involved in the effect of Retinoic Acid in preventing glomerulosclerosis. Involved in the docent program of the Department of Physiology -Universidad de Alcalá, Departamento de Fisiología. Alcalá de Henares, Madrid, SPAIN
01/2001-01/2003-Post-Doctoral Fellow, involved in the Screening for new targets responsible of the funtional regionalization of the mouse cerebral cortex.Max-Planck Institute of Biophycal Chemistry. Department of Molecular and Cell Biology. Göttingen, Germany.
Other Experiences and Achievements
2004 Supervisor-Co-director of a PhD student
2005, now Supervisor of two technical assistants
2003 Visiting Professor, Medicine Faculty. Alcala University. Madrid
1997-2000 PhD Study.Thesis: The role of Retinoic Acid: in vivo models Dr Lucio-Cazaña, Alcala University. Madrid
1996-1997 Diploma Thesis, Alcala University. Madrid
1991-1996 Pharmacy, Alcala University. Madrid.
Michal Schwartz is a Professor of Neuroimmunology at The Weizmann Institute of Science in Rehovot, Israel. She is married and has four children.
Schwartz’s work focuses on the role of innate and adaptive immunity in central nervous system (CNS) plasticity in health and disease. She was the first to claim that blood monocytes are needed for CNS repair, and that the integrity of the immune system is pivotal for neural tissue survival, repair and renewal. She pioneered the concept of “protective autoimmunity” and its role in CNS maintenance, cognitive and mental activity, and cell renewal from adult stem cells in the healthy and the diseased CNS. Her work has led to a paradigm shift in the perception of the cross talk between the CNS and immune cells, from viewing the brain as a tissue that is protected against immune cell entry, to a tissue that is protected by immune cell activity. Her publications include numerous peer-reviewed articles and invited reviews, many of which appear in the highest ranked journals (e.g., Nature Medicine, Nature Neuroscience, Nature Cell Biology, Nature Reviews Neuroscience, Nature Reviews Neurology, Proc. Natl. Acad. Sci., Science, Journal Clinical Invest., PlosMedicine, Journal Experimental Medicine). Schwartz has received a number of prestigious awards for her research: The 2002 Friedenwald Award from ARVO (Association for Research in Vision and Ophthalmology), for her outstanding contribution to vision research and ophthalmology; the Distinguished G. Heiner Sell Memorial Lectureship in 2002 for outstanding achievement in the field of spinal cord injury by the American Spinal Cord Injury Association; NARSAD (The Mental Health Research Association) Distinguished Investigative Award (2007); an award as a distinguished investigator from the European Commission (2008); an honorary doctorate from Ben-Gurion University (2009); and the Shaked Brain research award from Bar-Ilan University for her pioneering research (2009). Professor Schwartz has been invited as a keynote and plenary lecturer at numerous international meetings (more than 2000), and is an elected member of the International and European Societies for Neuroimmunology. Her pioneering view of the cross-talk between the immune and the nervous systems is a basis for searching for biological markers and developing therapies not hitherto considered for chronic neurodegenerative disorders, for mental disorders, and for rejuvenating the immune system as a way of arresting brain senescence and dementia.